Tyler Conklin

Tight End

Age: 29
Free Agency: 2025 (Void)
Accrued Seasons: 6
  • 2024 Salary Cap Charge: $5,358,334 (2.06% of cap)
  • 2024 Cash Payout: $6,750,000 (2.77% of spending)
  • 2024 Cash to Cap Ratio: 1.26
  • Contract Value: $20,250,000 ($6,750,000 APY)
  • Fully Guaranteed Money: $10,000,000
  • Contract Ranking: 19/162 at TE

Current Contract

(UFA, signed 2022)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusPer Game Roster BonusOther BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202227$1,035,000$1,688,333$650,000$250,000$1,035,000$3,623,3331.7%
202328$2,850,000$2,338,333$650,000$250,000$2,850,000$6,088,3332.7%
202429$1,125,000$3,333,334$650,000$250,000$0$5,358,3342.1%
2025 📝
February 10: Contract voids on 5th day of waiver period
30Void$1,645,000VoidVoidVoid$5,930,0002.0%
202631Void$1,645,000VoidVoidVoid$00.0%
202732Void$1,645,000VoidVoidVoid$00.0%
202833Void$995,000VoidVoidVoid$0--
Total$5,010,000$13,290,000$1,950,000$750,000$3,885,000$21,000,000

Contract Notes

Tyler Conklin signed a three year, $20.25 million contract with the Jets. The contract has $10 million in guarantees at signing.

Cash Flows

- fully earned money
- unearned or partially earned money
$6.8M
$13.5M
$20.3M
202220232024
Cash Due$6,750,000$6,750,000$6,750,000
Running Cash$6,750,000$13,500,000$20,250,000
Career Earnings: $17,001,032
Career APY: $2,833,505
Potential Earnings: $23,751,032
Total Guarantees: $10,281,032
Largest Cash Payment: $7,000,000 (2022)
Largest Cap Number: $6,088,333 (2023)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
VikingsDraftedExpired20184$2,741,032$685,258$281,032$3,001,032109.5%$750,258
JetsUFAActive20223$20,250,000$6,750,000$10,000,000$14,000,00069.1%$7,000,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Vikings4$3,001,032$750,258$3,001,0320.0%$00.0%
Jets2$14,000,000$7,000,000$9,711,6660.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusPer Game Roster BonusOther BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2018Vikings$480,000$70,258$0$0$0$550,2580.3%$761,032
2019Vikings$570,000$70,258$0$0$0$640,2580.3%$570,000
2020Vikings$750,000$70,258$0$0$0$820,2580.4%$750,000
2021Vikings$920,000$70,258$0$0$0$990,2580.5%$920,000
2022Jets$1,035,000$1,688,333$650,000$250,000$1,035,000$3,623,3331.7%$7,000,000
2023Jets$2,850,000$2,338,333$650,000$250,000$2,850,000$6,088,3332.7%$7,000,000
2024Jets$1,125,000$3,333,334$650,000$250,000$0$5,358,3342.1%$6,750,000
2025Jets$1,255,000$1,645,000$0$0$0$5,930,0002.0%$0
2026Jets$1,300,000$1,645,000$0$0$0$00.0%$0
2027Jets$1,345,000$1,645,000$0$0$0$00.0%$0
2028Jets$50,000,000$995,000$0$0$0$0--$0
Total$61,630,000$13,571,032$1,950,000$750,000$3,885,000$24,001,032$23,751,032

Statistics

YearGames PlayedGames InactiveSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
2018160014.0%34.2%000.0057715.4000
2019151026.6%36.9%000.008587.3000
2020160041.4%42.3%000.001919410.2100
2021170081.0%0.2%000.00615939.7300
2022170077.3%28.0%231.50585529.5300
2023170070.1%2.7%100.006162110.2000
202440091.8%10.6%000.001112611.5000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$7,685,000$6,750,000
Injury Adjusted$7,685,000$6,750,000
test
OTC Valuation $1.7M $3.4M $5.1M $6.9M $8.6M APY $2.9M $5.7M $8.6M $11.4M $14.3M $6,263,000 $7,000,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.